Insulin degludec improves health-related quality of life (SF-36® ) compared with insulin glargine in people with Type 2 diabetes starting on basal insulin: a meta-analysis of phase 3a trials.
about
Combination therapies in the management of type 2 diabetes: the use of insulin degludec/liraglutideInsulin Degludec in Clinical Practice: A Review of Japanese Real-World Data.Insulin degludec versus insulin glargine in type 1 and type 2 diabetes mellitus: a meta-analysis of endpoints in phase 3a trials.A comparison of health-related quality of life (health utility) between insulin degludec and insulin glargine: a meta-analysis of phase 3 trials.Efficacy and safety of insulin degludec in Japanese patients with type 1 and type 2 diabetes: 24-week results from the observational study in routine clinical practice.Treat-to-target trials in diabetes.Insulin degludec and insulin degludec/insulin aspart: a review of their use in the management of diabetes mellitus.Basal insulin analogues in the management of diabetes mellitus: What progress have we made?Clinical and cost-effectiveness of insulin degludec: from clinical trials to clinical practice.Health status and hypoglycaemia with insulin degludec versus insulin glargine: a 2-year trial in insulin-naïve patients with type 2 diabetes.Improved Glycemic Control Achieved by Switching to Insulin Degludec in Insulin-Treated Patients with Type 2 Diabetes in a Real-World Setting: a Non-interventional, Retrospective Cohort Study.Quality-of-life and treatment satisfaction in actual clinical practice of patients with Type 1 diabetes mellitus (T1DM) and hypoglycemia treated with insulin degludec.When insulin degludec enhances quality of life in patients with type 2 diabetes: a qualitative investigation.Cost-Effectiveness of Insulin Degludec Versus Insulin Glargine U100 in Patients with Type 1 and Type 2 Diabetes Mellitus in Serbia.
P2860
Q26751359-EE382C21-994B-4838-9A73-D63CE2C88A98Q31154873-7C60B801-B234-457A-8BDC-AD5D3F6E15BFQ34726423-06C5B332-1BAC-4EDE-8C83-891679622C17Q34981168-AC7D4B0F-7D1E-4259-8361-A21EFCB4A2C1Q36477634-9CA14895-15AF-4B65-811C-C069E493FD95Q37703688-A39E8043-815B-426C-84D9-0BBC5AD68742Q38101891-4EBF20B3-4CF9-4938-BA60-3EB5A0F0CAA5Q38136581-BC8A80D5-FA65-40BA-88F1-735057365945Q38470334-CDB53BE0-391E-4A9A-AD89-E571B040E133Q42213808-7183E463-3C50-4E0A-B02D-BA8854F17C4BQ42371741-B80D0800-5197-4C04-ACD6-96AB1D7B6270Q50195979-BF2C831B-E0E8-438B-888D-2A4CD240B39AQ55130319-F3D8E89F-F38F-4393-A937-280DA11194DBQ55262528-82810E09-B071-47CB-A86A-0C22DD36E71E
P2860
Insulin degludec improves health-related quality of life (SF-36® ) compared with insulin glargine in people with Type 2 diabetes starting on basal insulin: a meta-analysis of phase 3a trials.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
2013年论文
@zh
2013年论文
@zh-cn
name
Insulin degludec improves heal ...... a-analysis of phase 3a trials.
@ast
Insulin degludec improves heal ...... a-analysis of phase 3a trials.
@en
type
label
Insulin degludec improves heal ...... a-analysis of phase 3a trials.
@ast
Insulin degludec improves heal ...... a-analysis of phase 3a trials.
@en
prefLabel
Insulin degludec improves heal ...... a-analysis of phase 3a trials.
@ast
Insulin degludec improves heal ...... a-analysis of phase 3a trials.
@en
P2093
P2860
P356
P1433
P1476
Insulin degludec improves heal ...... ta-analysis of phase 3a trials
@en
P2093
L Meneghini
M L Wolden
T Christensen
P2860
P304
P356
10.1111/DME.12086
P577
2013-02-01T00:00:00Z